Form 4 for CRL Charles River Laboratories
Accepted 2022-03-04 00:00:00 ET · period of report 2022-03-03 · accession 0001127602-22-008258 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-04 | 2022-03-03 | CRL | Smith David Ross | CFO, Corp. Executive VP | M - OptEx | $136.60 | +8,965 | 29.7K | +43% | +$1.22M |
| DM | 2022-03-04 | 2022-03-03 | CRL | Smith David Ross | CFO, Corp. Executive VP | S - Sale+OE | $282.53 | -8,965 | 27.1K | -25% | -$2.53M |
| DM | 2022-03-04 | 2022-03-03 | CRL | Smith David Ross | CFO, Corp. Executive VP | M - OptEx | $0.00 | -8,965 | 5,446 | -62% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-03 | M | A | 1,815 | $179.66 | 34,784 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-03 | S | D | 3,825 | $281.49 | 30,959 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $280.98 to $281.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-03-03 | M | A | 3,304 | $144.67 | 32,969 | D | — | — | |
| 4 | Common | Common Stock | 2022-03-03 | M | A | 3,846 | $109.34 | 29,665 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-03 | S | D | 2,606 | $282.56 | 28,353 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $281.98 to $282.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2022-03-03 | S | D | 387 | $285.16 | 25,819 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $285.09 to $285.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2022-03-03 | S | D | 858 | $284.58 | 26,206 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $284.28 to $284.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Common | Common Stock | 2022-03-03 | S | D | 1,289 | $283.41 | 27,064 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $283.00 to $283.7. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 9 | Derivative | Stock Options (Right to Buy) | 2022-03-03 | M | D | 3,846 | $0.00 | 0 | D | $109.34 · 2019-02-23 to 2023-02-23 | 3,846 Common Stock | |
| 10 | Derivative | Stock Options (Right to Buy) | 2022-03-03 | M | D | 3,304 | $0.00 | 3,305 | D | $144.67 · 2020-02-22 to 2024-02-22 | 3,304 Common Stock | |
| 11 | Derivative | Stock Options (Right to Buy) | 2022-03-03 | M | D | 1,815 | $0.00 | 5,446 | D | $179.66 · 2021-05-29 to 2030-05-29 | 1,815 Common Stock |